A 1:1 blend by mass of CJC-1295 (No DAC) and Ipamorelin supplied for controlled research environments. This co-formulation is suitable for studies exploring GHRH-receptor and ghrelin (GHS-R1a)–receptor signaling pathways when evaluated together in model systems.
Composition
CJC-1295 (Without DAC): 5 mg
Ipamorelin: 5 mg
Appearance: Lyophilized powder in a sealed research vial
Research Focus (non-clinical)
Comparative and combined pathway evaluation of GHRH analog + GHS agonist in in-vitro or ex-vivo models
Assessment of assay development, including chromatographic separation of co-formulated peptides
Stability characterization of a two-analyte lyophilized blend under laboratory storage conditions
Documentation
Lot-specific COA available
Batch and lot traceability
Important Notice
For research use only
Not for human consumption
Not intended to diagnose, treat, cure, or prevent any disease
Quality Manufacturing
Lot-specific COA
Lyophilized for transit stability; batch traceable
Tamper-evident seal; lot test date on each vial
No MOQ for online orders
Bulk orders for physical locations start at 25-unit minimum
Products listed are intended for research purposes only.
| Trust Grade | Action | |||
|---|---|---|---|---|
Your Peptide Brandwc_2797 | D | Price on request | In Stock | Buy |
Sign in to view price trends and track how prices change over time.
No reviews yet - be the first to review this product!